Gut 61:1657-1669 doi:10.1136/gutjnl-2011-301748
  • Guidelines

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

  1. Harpreet Wasan7
  1. 1Department of Hepatology and Gastroenterology Section, Imperial College London, London, UK
  2. 2Department of Hepatobiliary Surgery, Division of Medicine, University College London, London, UK
  3. 3Department of Medicine and Department of Histopathology, Imperial College London, London, UK
  4. 4Department of Hepatobiliary and Pancreatic Surgery, King's College Hospital, London, UK
  5. 5UCL Institute of Liver and Digestive Health, Division of Medicine, University College London, London, UK
  6. 6Department of Radiology, Imperial College London, London, UK
  7. 7Department of Oncology, Imperial College London Hammersmith Hospital Campus, London, UK
  1. Correspondence to Dr Shahid A Khan, Division of Medicine, Imperial College London, Liver Unit, 10th Floor, QEQM Wing, St Mary's Hospital Campus, South Wharf Road, London W2 1NY, UK and Department of Gastroenterology, 3rd Floor, Hammersmith House, Hammersmith Hospital Campus, Du Cane Road, London W12 0HS, UK; shahid.khan{at}
  1. Contributors SAK wrote the original draft of this manuscript and subsequently coordinated input from the co-authors, all of whom have contributed to the sections of the document relevant to their specialty and field(s) of interest, as well as the overall manuscript.

  • Revised 10 July 2012
  • Accepted 13 July 2012
  • Published Online First 15 August 2012


The British Society of Gastroenterology guidelines on the management of cholangiocarcinoma were originally published in 2002. This is the first update since then and is based on a comprehensive review of the recent literature, including data from randomised controlled trials, systematic reviews, meta-analyses, cohort, prospective and retrospective studies.


  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.